We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-6.00 | -0.33% | 1,813.00 | 1,810.00 | 1,811.00 | 1,838.00 | 1,804.00 | 1,818.00 | 365,955 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 192M | 0.8685 | 20.85 | 4B |
TIDMHIK
RNS Number : 1838Q
Hikma Pharmaceuticals Plc
04 June 2018
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities / person closely associated --- --------------------------------------------------------------- a) Name Said Darwazah --- --------------------- ---------------------------------------- 2 Reason for the notification --- --------------------------------------------------------------- a) Position/status Executive Chairman --- --------------------- ---------------------------------------- b) Initial notification Initial notification /Amendment --- --------------------- ---------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name Hikma Pharmaceuticals PLC --- --------------------- ---------------------------------------- b) LEI 549300BNS685UXH4JI75 --- --------------------- ---------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description Description: Ordinary shares of 10 of the financial pence each instrument, ID Code: GB00B0LCW083 type of instrument and identification code --- --------------------- ---------------------------------------- b) Nature of Release of a pledge by Darhold Limited the transaction over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.76%. --- --------------------- ---------------------------------------- c) Price(s) and Price(s): GBP0.00p volume(s) Volume(s): 1,800,000 --- --------------------- ---------------------------------------- d) Aggregated Aggregated volume: 1,800,000 information Price: GBP0.00p --- --------------------- ---------------------------------------- e) Date of the 4 June 2018 transaction --- --------------------- ---------------------------------------- f) Place of the Amman transaction --- --------------------- ----------------------------------------
Mazen Darwazah
1 Details of the person discharging managerial responsibilities / person closely associated --- --------------------------------------------------------------- a) Name Mazen Darwazah --- --------------------- ---------------------------------------- 2 Reason for the notification --- --------------------------------------------------------------- a) Position/status Executive Vice Chairman --- --------------------- ---------------------------------------- b) Initial notification Initial notification /Amendment --- --------------------- ---------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- --------------------------------------------------------------- a) Name Hikma Pharmaceuticals PLC --- --------------------- ---------------------------------------- b) LEI 549300BNS685UXH4JI75 --- --------------------- ---------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- --------------------------------------------------------------- a) Description Description: Ordinary shares of 10 of the financial pence each instrument, ID Code: GB00B0LCW083 type of instrument and identification code --- --------------------- ---------------------------------------- b) Nature of Release of a pledge by Darhold Limited the transaction over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 10.96%. --- --------------------- ---------------------------------------- c) Price(s) and Price(s): GBP0.00p volume(s) Volume(s): 1,800,000 --- --------------------- ---------------------------------------- d) Aggregated Aggregated volume: 1,800,000 information Price: GBP0.00p --- --------------------- ---------------------------------------- e) Date of the 4 June 2018 transaction --- --------------------- ---------------------------------------- f) Place of the Amman transaction --- --------------------- ----------------------------------------
Mohammed 'Ali' Al-Husry
1 Details of the person discharging managerial responsibilities / person closely associated --- ---------------------------------------------------------------- a) Name Mohammed 'Ali' Al-Husry --- --------------------- ----------------------------------------- 2 Reason for the notification --- ---------------------------------------------------------------- a) Position/status Non-Executive Director --- --------------------- ----------------------------------------- b) Initial notification Initial notification /Amendment --- --------------------- ----------------------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor --- ---------------------------------------------------------------- a) Name Hikma Pharmaceuticals PLC --- --------------------- ----------------------------------------- b) LEI 549300BNS685UXH4JI75 --- --------------------- ----------------------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted --- ---------------------------------------------------------------- a) Description Description: Ordinary shares of 10 of the financial pence each instrument, ID Code: GB00B0LCW083 type of instrument and identification code --- --------------------- ----------------------------------------- b) Nature of Release of a pledge by Darhold Limited the transaction over 1,800,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Europe Arab Bank Plc. The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.05%. --- --------------------- ----------------------------------------- c) Price(s) and Price(s): GBP0.00p volume(s) Volume(s): 1,800,000 --- --------------------- ----------------------------------------- d) Aggregated Aggregated volume: 1,800,000 information Price: GBP0.00p --- --------------------- ----------------------------------------- e) Date of the 4 June 2018 transaction --- --------------------- ----------------------------------------- f) Place of the Amman transaction --- --------------------- -----------------------------------------
Peter Speirs
Company Secretary, responsible for releasing this announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGCGDLRDGBGIS
(END) Dow Jones Newswires
June 04, 2018 05:29 ET (09:29 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions